Clinical trials
Lung Diseases trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Terminated | 4 |
| Unknown status | 4 |
| Enrolling by invitation | 2 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 7 |
| Bayer | 3 |
| Federal University of Minas Gerais | 2 |
| Pfizer | 2 |
| United Therapeutics | 2 |
| Apsen Farmaceutica S.A. | 1 |
| Biozeus Biopharmaceutical S.A. | 1 |
| Celgene | 1 |
| Centro Universitário Augusto Motta | 1 |
| Centro Universitário de Anapolis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 40 |
| Respiratory Tract Diseases | 11 |
| Pulmonary Disease, Chronic Obstructive | 8 |
| Lung Diseases, Obstructive | 6 |
| Bronchial Diseases | 5 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Cardiovascular Diseases | 5 |
| Asthma | 4 |
| COVID-19 | 4 |
| Coronavirus Infections | 4 |
Trials
Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.